Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Autops. Case Rep ; 8(3): e2018038, July-Sept. 2018. ilus
Article Dans Anglais | LILACS | ID: biblio-911892

Résumé

Disseminated mycosis (DM)­with cardiac involvement and shock­is an unexpected and severe opportunistic infection in patients with yellow fever. DM can mimic bacterial sepsis and should be considered in the differential diagnosis of causes of systemic inflammatory response syndrome in this group of patients, especially in areas where an outbreak of yellow fever is ongoing. We report the case of a 53-year-old male patient who presented to the emergency department with fever, myalgia, headache, and low back pain. The laboratory investigation revealed a positive molecular test for yellow fever, hepatic injury, and renal failure. During hospitalization, the patient developed hepatic encephalopathy, ascending leukocytosis, and ascites, with signs consistent with peritonitis. On the 11th day of hospitalization, the patient developed atrioventricular block, shock and died. At autopsy, angioinvasive mycosis was evidenced mainly in the heart, lungs, kidneys, and adrenals.


Sujets)
Humains , Mâle , Adulte d'âge moyen , Infections fongiques invasives/complications , Fièvre jaune/complications , Autopsie , Diagnostic différentiel , Issue fatale , Infections fongiques invasives/anatomopathologie , Rein/traumatismes , Insuffisance rénale/complications
2.
Rev. méd. Minas Gerais ; 19(4,supl.3): S64-S68, out.-dez. 2009. ilus
Article Dans Portugais | LILACS | ID: lil-568873

Résumé

Este trabalho salienta a possibilidade de a alteração do excipiente de medicamentos tomados por longos períodos desencadear a Necrólise Epidérmica Tóxica. É feita a descrição clínica de paciente de 30 anos com farmacodermia associada ao uso de antirretrovirais.


This work emphasizes the possibility that changing the excipient of some drugs taken over long periods can trigger Toxic Epidermic Necrolysis. This article shows the clinical aspects of a patient who took AZT/r since March/2007. Thus, the suspicion that this drug would trigger Stevens-Johnson syndrome isn’t significative. On the other hand, the fact that the antiretroviral vehicle has been changed leads to a strong suspicion that it could be involved in triggering this syndrome. It is reported the clinical description of a 30-year patient eruption associated with the use of retroviral.


Sujets)
Humains , Mâle , Adulte , Syndrome de Stevens-Johnson , Thérapie antirétrovirale hautement active , Excipients pharmaceutiques
SÉLECTION CITATIONS
Détails de la recherche